Addex Therapeutics Ltd.
ADXN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574232
No open-market purchases or sales by Addex Therapeutics Ltd. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $274 in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Addex Therapeutics Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Addex Therapeutics Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Teyssedou Lenaic Nathanael | PRINCIPAL ACCOUNTING OFFICER | – | Sep 4, 2026 | 1 |
| Kalinichev Mikhail | HEAD OF TRANSLATIONAL SCIENCE | 306,765 | Sep 4, 2026 | 1 |
| Nunn Jason Raleigh | Director | 219,561 | Sep 4, 2026 | 1 |
| Mills Roger | CHIEF MEDICAL OFFICER | 785,976 | Sep 4, 2026 | 1 |
| Manke Isaac | Director | 219,561 | Sep 4, 2026 | 1 |
| Lawton Vincent Michael | Director | 2,507,987 | Sep 4, 2026 | 1 |
| Hill Raymond George | Director | 1,365,532 | Sep 4, 2026 | 1 |
| Dyer Timothy Mark | CHIEF EXECUTIVE OFFICER | 16,848,979 | Sep 4, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.